Displaying drugs 1801 - 1825 of 2797 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Levoketoconazole | 531.431 C26H28Cl2N4O4 |  | One of two enantiomeric forms of racemic ketoconazole that strongly inhibits multiple steroidogenic enzymes and is used for the symptomatic treatment of endogenous Cushing's syndrome. | Anticorticosteroids |
| Toremifene | 405.96 C26H28ClNO |  | A first generation nonsteroidal selective estrogen receptor modulator used to treat certain breast cancers. | Anti-Estrogens |
| Clomifene | 405.96 C26H28ClNO |  | A medication used to induce ovulation. | Ovulation Stimulants, Synthetic |
| Cinnarizine | 368.524 C26H28N2 |  | A drug used for the management of labyrinthine disorder symptoms, including vertigo, tinnitus, nystagmus, nausea, and vomiting. | Antivertigo Preparations |
| Pyrvinium | 382.53 C26H28N3 |  | An anthelmintic agent used for the treatment of pinworm infestations. | Anthelmintics / Antiparasitic Agents |
| Vibegron | 444.535 C26H28N4O3 |  | A beta-3 adrenergic agonist the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults. | Adrenergic Agonists / Adrenergic beta-3 Receptor Agonists / Adrenergic beta-Agonists / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Drugs for Urinary Frequency and Incontinence / Genito Urinary System and Sex Hormones / Genitourinary Smooth Muscle Relaxants / P-glycoprotein substrates / Pyrimidines / Selective Beta 3-adrenergic Agonists / Urologicals |
| Omidenepag isopropyl | 520.61 C26H28N6O4S |  | An agonist of the prostaglandin EP2 receptor indicated for the reduction of elevated intraocular pressure. | Antiglaucoma Agents / Hypotensive Agents / Ophthalmic Solutions / Ophthalmics / Prodrugs / Pyrazoles / Pyridines / Receptors, Prostaglandin E, EP2 Subtype, agonists / Sulfonamides |
| Bosutinib | 530.446 C26H29Cl2N5O3 |  | An antineoplastic agent used for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adults with inadequate clinical response to other treatments. | Bcr-Abl Tyrosine Kinase Inhibitors / Protein Kinase Inhibitors |
| Almitrine | 477.5522 C26H29F2N7 |  | For the treatment of chronic obstructive pulmonary disease. | Respiratory System Agents |
| Levocabastine | 420.528 C26H29FN2O2 |  | A selective histamine H1 receptor antagonist indicated for the management of seasonal allergic conjunctivitis symptoms. | Antiallergic Agents, Excl. Corticosteroids |
| Choline magnesium trisalicylate | 539.814 C26H29MgNO10 |  | Choline magnesium trisalicylate is used to reduce pain and inflammation caused by conditions such as arthritis. This medication is also used to treat fever in adults. | Agents that produce hypertension |
| Tirbanibulin | 431.536 C26H29N3O3 |  | A tyrosine kinase and tubulin inhibitor used to treat actinic keratosis on the face or scalp. | Enzyme Inhibitors / Microtubule Inhibitors |
| Nicardipine | 479.525 C26H29N3O6 |  | A calcium channel blocker used for the short-term treatment of hypertension and chronic stable angina. | Dihydropyridine Derivatives |
| Tamoxifen | 371.5146 C26H29NO |  | A selective estrogen receptor modulator used to treat estrogen receptor positive breast cancer, reduce the risk of invasive breast cancer following surgery, or reduce the risk of breast cancer in high risk women. | Anti-Estrogens |
| Halofantrine | 500.424 C26H30Cl2F3NO |  | An antimalarial used for the treatment of severe malaria. | Agents that reduce seizure threshold / Antiprotozoals |
| Macimorelin | 474.565 C26H30N6O3 |  | A medication used to treat adult growth hormone deficiency. | Tests for Pituitary Function |
| Aclidinium | 484.651 C26H30NO4S2 |  | An inhaled long-acting anticholinergic used as a maintenance bronchodilator in patients with chronic obstructive pulmonary disease (COPD). | Agents producing tachycardia |
| Terconazole | 532.47 C26H31Cl2N5O3 |  | An antifungal drug used in the treatment of vulvovaginal candidiasis. | Triazole Derivatives |
| Infigratinib | 560.475 C26H31Cl2N7O3 |  | An FGFR inhibitor used to treat locally advanced or metastatic cholangiocarcinoma in adults with a fibroblast growth factor receptor 2 (FGFR2) rearrangement. | Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors |
| Ensifentrine | 477.565 C26H31N5O4 |  | A phosphodiesterase inhibitor used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. | BCRP/ABCG2 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 Substrates / Heterocyclic Compounds, Fused-Ring / Phosphodiesterase 3 Inhibitors / Phosphodiesterase 4 Inhibitors / Phosphodiesterase Inhibitors / Pyrimidines |
| Fluocinonide | 494.5249 C26H32F2O7 |  | A high potency corticosteroid commonly used topically for a number of inflammatory skin conditions. | Corticosteroids, Potent (Group III) |
| Tritoqualine | 500.548 C26H32N2O8 |  | Not Annotated | Cholagogues and Choleretics |
| Selexipag | 496.63 C26H32N4O4S |  | A non prostanoid IP prostacyclin receptor agonist used to treat pulmonary arterial hypertension. | Platelet Aggregation Inhibitors Excl. Heparin |
| Lacidipine | 455.551 C26H33NO6 |  | A lipophilic dihydropyridine calcium channel blocker with a slow onset of action used to treat hypertension. | Dihydropyridine Derivatives |
| Elexacaftor | 597.66 C26H34F3N7O4S |  | A small molecule CFTR corrector used in combination with tezacaftor and ivacaftor for the treatment of cystic fibrosis patients with one F508del-CFTR mutation. | Cystic Fibrosis Transmembrane Conductance Regulator Correctors / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP2D6 Inhibitors / Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A4 Substrates (strength unknown) / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Membrane Transport Modulators / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / P-glycoprotein inhibitors / P-glycoprotein substrates |
Displaying drugs 1801 - 1825 of 2797 in total